Targeted peptide hydrogel may enhance BCG therapy for bladder cancer
Bladder cancer BCG therapy side effects may be reduced by a new hydrogel designed to prevent drug washout and improve treatment tolerance.
Bladder cancer BCG therapy side effects may be reduced by a new hydrogel designed to prevent drug washout and improve treatment tolerance.
A recent study found limited survival benefits for advanced bladder cancer patients after initial therapy stops working.
A large study shows that tumors in the bladder neck or trigone increase the risk of bladder cancer returning or advancing to a later stage.
A new study shows how AI and inflammation markers provide a personalized look at survival for patients following bladder cancer surgery.
A recent study found low vitamin D levels are associated with a 32% higher risk of developing bladder cancer.
A study suggests that undergoing surgery within 14 days significantly improves survival for patients with muscle invasive bladder cancer.